Insulin Pump Therapy for Adults with Type 2 Diabetes
Insulin Pump Therapy for Adults with Type 2 Diabetes
Written by Hope Warshaw, MMSc, RD, CDE, BC-ADM, FADCES
Many people with type 2 diabetes need to take insulin to manage their glucose levels. The need for insulin may increase when a person has had type 2 diabetes for a long time. In the early years of having type 2 diabetes a person’s pancreas can still produce some insulin but overtime the pancreas is no longer able to make sufficient amounts of insulin to achieve glucose targets.1 Additionally, research shows that many people with type 2 diabetes who take insulin still do not achieve the recommended targets for their glucose levels.2 The American Diabetes Association recommends that people with type 2 diabetes and their healthcare providers consider using insulin pump therapy as an alternative to taking injections of insulin.
Today there are several different types of insulin; two common types include rapid-acting insulin and long-acting insulin. Adults with type 2 diabetes who begin taking insulin may start with just one shot of long-acting insulin per day. Over time they may need to add one or more mealtime insulin injections to keep their glucose levels within their target range. This is called multiple daily injections (MDI) using rapid- and long-acting insulin. Alternatively the individual can use an insulin pump. Everyone on an insulin pump uses just one type of insulin: rapid-acting. Using insulin pump therapy can simplify the task of taking insulin and reduce the physical and mental burdens of managing diabetes.
As you learn the basics of insulin pump therapy in this article, think about whether it is right for you or your loved one.
What are the basics of insulin pump therapy for type 2 diabetes?
An insulin pump delivers insulin, similar to an injection, right under the skin or subcutaneously. What is different is that the insulin pump user gets some of their insulin delivered continuously all day long. The insulin is delivered through a narrow tube that is placed by a thin, short needle just under the skin. Insulin pump therapy uses just one type of insulin, rapid-acting. The pump delivers insulin as it is directed by the user’s settings in two ways – basal and bolus.1 Settings in the insulin pump are prescribed and guided by the person’s diabetes healthcare providers.
What do the terms basal and bolus mean with regard to insulin delivery?
Basal insulin is also known as background insulin. The pump delivers small amounts of rapid acting insulin continuously and automatically throughout the day at a rate determined by your provider.2 This is called the basal rate and provides the insulin a person needs to keep glucose levels within their target range in between meals and overnight. It replaces the need for long-acting insulin. A benefit of insulin pump therapy is that the basal rate can be adjusted based on the user’s basal insulin needs. The user can set different rates for different time segments of the day when they need more or less insulin. For example, overnight they may need a different rate of insulin to help them wake up in range. Another benefit of an insulin pump is that the user can temporarily set their basal rate to deliver more or less insulin for a short period of time. This comes in handy for exercise, when less basal insulin might be needed and sick days, when more basal insulin might be needed.
Bolus insulin is the insulin that is delivered for meals or to correct a high blood glucose.2 The user will prompt the pump to deliver the bolus insulin dose when needed. Depending on the functionalities of the pump, the user can choose to take the bolus dose all at once or to extend all or part of it over a number of hours. This is often used for foods or meals that are elevating blood glucose levels longer than usual.
When can a person with type 2 diabetes start insulin pump therapy?
A person with type 2 diabetes can successfully start insulin pump therapy from the time they are prescribed insulin.3 If insulin pump therapy is something that you and/or your caregivers believe would benefit your diabetes management discuss this with your diabetes healthcare providers.
How many insulin pumps are available and how are they tested?
Today there are several companies that manufacture insulin pumps around the globe. Prior to being made available for purchase, these insulin delivery devices are thoroughly tested by the manufacturer and reviewed by regulatory authorities, such as the Food and Drug Administration (FDA) in the U.S. Once a device is given approval to be sold, it must be prescribed to the person with type 2 diabetes by their healthcare provider. Along with the prescription, the healthcare provider gives specific instructions for how the insulin pump should be programmed. After receiving the pump, the person with type 2 diabetes and their caregivers are taught how to use it. This is done by a healthcare provider, typically a Certified Diabetes Care and Education Specialist (CDCES), that is also a Certified Pump Trainer (CPT) for the chosen pump. The person with type 2 diabetes will learn the basics of insulin pump therapy and the specifics about their particular pump. In addition, manufacturers provide 24/7 customer support to people who use their system.
What are the two main types of insulin pumps?
A traditional insulin pump has tubing.3 The tubing goes from the insulin pump to a site on the user’s body. The site is called an infusion set and includes a smaller tube, called a cannula, that the user inserts under the skin using a needle. The insulin pump itself, which holds the insulin and is the interface to deliver a bolus or change settings, is worn on the body—e.g., clipped at the waist, in a woman’s bra, in a pouch around the waist or in a pocket. The infusion set can be placed on the body almost anywhere insulin can be injected such as the abdomen, lower back, leg, arm or buttocks.
The other type of insulin pump is a tubeless pump. In a tubeless system, a Pod that is filled with insulin is worn directly on the body almost anywhere insulin can be injected, similar to the tubed pump. The Pod has an integrated infusion set and automatically inserts the cannula under the skin. The other piece of the tubeless system is the controller that is used to direct the actions of the Pod. A big benefit of this system is that this controller only needs to be near the user to deliver a bolus or change settings. Therefore, the controller device does not need to be worn on the body.
The insulin pump user needs to change their infusion set and pump tubing or Pod site every two or three days. Another benefit of a tubeless insulin pump is not having to deal with the inconveniences and challenges of the long tubing becoming snagged or tangled, which can pull out the infusion set.
Insulin pumps have been available for four decades.1,3 Through the years insulin pumps have gotten much smaller and easier to use. In addition, new features have been added to make insulin delivery easier and more convenient as well as features that can potentially reduce hypoglycemia (low glucose levels) and hyperglycemia (high glucose levels). Such as the ability to consider active insulin from a previous bolus also called ‘insulin on board”. Insulin pumps give more precise insulin doses compared to MDI such as bolus and basal increments as low as 0.025u. Over the last several years, as continuous glucose monitoring (CGM) has become more available to people with diabetes, several insulin pumps can integrate and provide CGM data to the user and their healthcare provider for more precise and easier management.
Are there additional benefits of insulin pump therapy for a person with type 2 diabetes?
Yes, here are some additional benefits below:2-4
Access by the user and their healthcare providers to all of the insulin pump data and reports.
Is insulin pump therapy right for me?
Choosing to start insulin pump therapy to manage your or a loved one’s type 2 diabetes is a decision that should be made in concert with a diabetes healthcare provider. Insulin pump therapy may be a good option for a person with type 2 diabetes if you:5,6
need and want an easier way to deliver insulin
have an unpredictable schedule that may result in varied insulin needs
need large amounts of basal and/or bolus insulin
have higher and lower basal insulin needs during the day
travel across time zones or do shift work
participate in athletics or exercise
want to give insulin discreetly
Is an insulin pump and the supplies typically a covered benefit by healthcare plans?
Learn More About the Benefits of Insulin Pump Therapy
Learn more by reading real life stories from people wearing pump therapy systems. Discover how insulin pump therapy is making a world of difference in their lives.
1: Cefalu WT, Dawes DE, Gavlak G, et al. Insulin accesss and affordability working group: Conclusions and recommendations. Diabetes Care. 2018;41(6):1299-1311.
2: UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998; 352(9131): 854–865.
3: American Diabetes Association. 6. Glycemic Targets: standards of medical care in diabetes - 2021. Diabetes Care.2021;44(suppl 1):S73—S84.
4: American Diabetes Association. 7. Diabetes technology: standards of medical care in diabetes - 2021. Diabetes Care.2021;44(suppl 1):S85-S99.
5: Walsh J, Roberts R. Pumping insulin, 5th ed.Torrey Pines Press. 2012.
6: Sikes KA, Weyman K. Diabetes and the use of insulin pumps. Endocrin Advisor. https://www.endocrinologyadvisor.com/home/decision-support-in-medicine/endocrinology-metabolism/diabetes-and-the-use-of-insulin-pumps/. Accessed March 3, 2021.
7: Scheiner G. Think like a pancreas. 3rd ed. Hachette Books. 2020.
8: Anders L. Carlson, Lauren M. Huyett, Jay Jantz, Albert Chang, Todd Vienneau, Trang T. Ly, Improved glycemic control in 3,592 adults with type 2 diabetes mellitus initiating a tubeless insulin management system. Diabetes Research and Clinical Practice; 2021; 174, 108735.
9: Aronson R, Reznik Y, Conget I, et al.; OpT2mise Study Group. Sustained efficacy of insulin pump therapy compared with multiple daily injections in type 2 diabetes: 12-month data from the OpT2mise randomized trial. Diabetes Obes Metab 2016;18:500–507